AzTrials
AzTrials

AgingNCT03406195

Modulation of Episodic Memory Using Theta Burst Stimulation (TBS)

A study testing Transcranial magnetic stimulation (TMS) in people with Aging, run by Duke University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The goal of this study is to evaluate the effect of white matter guided theta burst stimulation on episodic memory task performance in healthy older adults. The investigators aim to propagate the effect of theta burst stimulation from a superficial locus of stimulation (angular gyrus) to hippocampus and… Read more about this study

Who is it for?
Ages 60 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Aging
What is being tested?
Transcranial magnetic stimulation (TMS)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
15 Dec 2018to 30 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy controls in the age group 60-80 years old
  • No other Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 axis 1 diagnoses
  • Willing to provide informed consent
  • Structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) data available

Who cannot join

  • Subjects are unable or unwilling to give informed consent
  • Presence of any organic brain illness
  • Presence or history of stroke, traumatic brain injury or head injury with loss of consciousness, transient ischemic attack (TIA), any diagnosed neurological disorder including but not limited to multiple sclerosis, Huntington's disease, Parkinson's disease, dementia or major neurocognitive disorder.
  • Presence of cranial metal implants, structural brain lesion including but not limited to cerebral aneurysms.
  • Presence of devices that may be affected by repetitive transcranial magnetic stimulation (rTMS) (pacemaker, medication pump, cochlear implant, implanted brain stimulator)
  • Current or recent (within the past 6 months) substance abuse or dependence, excluding nicotine and caffeine.
Show all 9Show fewer
  • Current serious medical illness
  • History of seizure except those therapeutically induced by electroconvulsive therapy (ECT) (childhood febrile seizures are acceptable and these subjects may be included in the study), history of epilepsy in self or first degree relatives
  • For subjects age > 59 years, a total scaled score < 8 on the Dementia Rating Scale-2.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke University Medical Center

    Durham, North Carolina, 27710

Other trials in United States

About this study

The goal of this study is to evaluate the effect of white matter guided theta burst stimulation on episodic memory task performance in healthy older adults. The investigators aim to propagate the effect of theta burst stimulation from a superficial locus of stimulation (angular gyrus) to hippocampus and parahippocampal regions using white matter tract connection between these regions. Study activities and population group - for the study plans to recruit 20 healthy older adults who already have white matter scans acquired as part of another study performed by the Cabeza Lab at Duke University.

Using tractography the exact site of stimulation on the cortical surface will be localized. An initial motor evoked potential (MEP) assessment will differentiate responders to theta burst stimulation from non responders. Responders will receive 1200 pulses of intermittent theta burst stimulation (iTBS) or sham stimulation to the angular gyrus while they perform the encoding portion of an episodic memory task. There after, they will perform retrieval piece of the task and data analysis will compare these performances.

Read the detailed description

Aims and Hypotheses The purpose of the study is to evaluate the effect of theta burst stimulation (TBS) which is a relatively new paradigm of transcranial magnetic stimulation (TMS) on episodic memory (EM) in healthy older adults (hOA).

Aim1: Evaluate the effect of theta burst stimulation (TBS) on episodic memory (EM) in healthy older adults. Hypothesis 1 - There will be significant improvement in EM compared to baseline with one session of TBS.

Aim 2: Correlate white matter integrity to improvement in task retrieval with TBS. Hypothesis 2- Stronger white matter (WM) tract connections correlate to greater improvement in retrieval performance.

BACKGROUND Alzheimer's disease (AD) affects 5 million Americans, at a cost of over 200 billion dollars. The first and most debilitating symptom of AD is a severe deficit in the ability to remembering personal past events, or episodic memory (EM), which eventually renders patients isolated from family and friends and unable to live independently. This EM deficit reflects primarily the deterioration of medial temporal lobe regions, particularly the hippocampus (HC). AD treatments must start very early in the disease progression, when brain damage is still small, and the earliest stage when AD can be diagnosed is known as mild cognitive impairment due to AD (MCI-AD).

Recently, different forms of noninvasive brain stimulation techniques have been applied to healthy older adults, AD and MCI-AD to improve memory impairment. Most of these trials used high-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the left dorsolateral prefrontal cortex (DLPFC). Although a small number of these studies have shown beneficial effects, considerable questions remain as to whether TMS has clinically relevant effects in elderly populations, as well as to what neuroscience-based mechanisms account for these effects. An obstacle for using TMS to enhance EM is that the brain region most critical for EM and most affected by early AD, the hippocampus (HC), is situated deep inside the brain, beyond TMS direct effects (~1" below the skull). One study attempted to target hippocampus and peri-hippocampal regions for stimulation via TMS. They stimulated the lateral parietal cortex and utilized functional connectivity between this region and hippocampus/peri-hippocampal regions (mainly entorhinal cortex) to enhance performance on an associative memory task. The inferior longitudinal fasciculus connects angular gyrus to hippocampus and para-hippocampal regions, and could propagate stimulation effects from cortical to subcortical structures, although studies on effect on TMS on white matter neuronal populations are limited as detailed below. The effect of TMS on neuronal populations in the white matter tracts was recently modeled using tractography and e-field calculations, and increasingly, these approaches need to account for what percentage of variance in motor threshold (MT) would be accounted for by white matter tracts.

TBS is a potent paradigm of TMS. As detailed in a seminal paper by Huang et al, there are 2 patterns for the paradigm: - continuous theta burst stimulation (cTBS) and intermittent theta burst stimulation (iTBS). The former produces suppression of MEP and the latter produces increase in MEP. iTBS delivers 50 Hz stimuli in packets of 10 lasting 2 seconds. Each stimulus burst delivered at 50 Hz is given every 200 milliseconds making the overall frequency of stimulus delivery 5 Hz. Hence the stimulation encompasses nested 50 Hz bursts (gamma frequency) given at 5 Hz (theta frequency). Most investigational studies which did not have treatment outcome measures have used either 40 second of cTBS or 190 seconds of iTBS. Both these paradigms have been shown to cause changes in MEP for 60 minutes. Variations in pattern of stimulation have also been effective, although there are limited studies to warrant its use. The investigators therefore propose to use stimulate the function of the hippocampal formation in healthy older adults (hOA) by targeting a cortical region directly connected to the hippocampal formation: the angular gyrus. To increase indirect effects on hippocampal formation, the investigators will use the most powerful TMS technique available, intermittent Theta Burst Stimulation (iTBS).

METHODOLOGY The study is designed to be a pilot one evaluating the effect of TBS on EM in healthy older adults (hOA). The investigators plan to screen 30 participants to select 20 subjects.

Screening Potential participants will be in the age group of 60-80 years and encompasses subjects who have been recruited to previous studies at Cabeza Lab (Pro00005021), hence having brain imaging data already collected.

Study procedure On day 1 of the study, subjects will have the National Institute of Health (NIH) Toolbox administered to them. The NIH toolbox is a comprehensive set of neuro-behavioral measurements that quickly assesses cognitive functions from the convenience of an iPad. Total time allotted for NIH toolbox administration is 45 minutes. Following this, subjects will have motor evoked potential (MEP) performed after which they will be administered intermittent theta burst stimulation (iTBS) to motor cortex. This will be followed by measurement of motor evoked potential (MEP) again. Subjects who do not show a 10 % increase in motor evoked potential (MEP) with iTBS will be excluded from further parts of the study.

Our study uses a specific kind of TMS, known as intermittent theta burst stimulation (iTBS). On day 1 of the study, subjects will be administered either left-sided iTBS to the motor cortex. The subject will be seated in a chair. Electromyogram (EMG) electrodes will be applied to the right hand for motor evoked potential (MEP) recording. For iTBS the active motor threshold would be 80 % as used in most theta burst studies detailed in this review. Subjects would receive iTBS comprising 50 Hz bursts given at 3 to 5 Hz for close to 3 minutes which comprises 19 trains and 600 pulses. The subject will be monitored until MEPs return to baseline. A side effects checklist will be completed at the beginning and at the end of the experimental session. All sessions will be performed by one of the protocol investigators, or by a trained and accredited research assistant supervised by the protocol investigators.

If a 10 % increase is seen in the MEP, then subjects will receive a second session of iTBS or sham stimulation to the left angular gyrus one hour after the screening session. If they receive iTBS, this will comprise 6 minutes of stimulation equivalent to 1200 pulses and 38 trains of the stimulus. The subject will be monitored until MEPs return to baseline. A side effects checklist will be completed at the beginning and at the end of the experimental session. Sham stimulation will use superficial electrodes to mimic the experience of receiving actual stimulation. All sessions will be performed by one of the protocol investigators, or by a trained and accredited research assistant supervised by the protocol investigators. Subjects will perform encoding trials of episodic memory task with stimulation and retrieval piece of the task after the stimulation.

Conditions
Aging
Being tested
Transcranial magnetic stimulation (TMS)
Keywords
transcranial magnetic stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial magnetic stimulation (TMS)Device

    TMS paradigm called theta burst stimulation

Study groups in NCT03406195
Study groupRoleWhat they receive
healthy older adultsExperimentalHealthy older adults who will receive TMS
Receives: Device: Transcranial magnetic stimulation (TMS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Episodic memory retrieval task decision

    Four-choice decision (1- definitely there is a link, 2-probably there is a link, 3-probably there is no link, 4-definitely there is no link) in response to semantic link retrieval between 2 words

    Measured: 40 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2018
  2. Study start15 Dec 2018 (estimated)
  3. Primary completion30 Dec 2019 (estimated)
  4. Study completion30 Dec 2019 (estimated)

Why it stopped: No participants recruited, IRB closed

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
We will perform episodic memory task before and after the TMS session
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03406195
Sponsor's protocol ID
Pro00086794
Status last verified
Sep 2018
First submitted
16 Jan 2018
Last updated
6 Sep 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Publications

  • Trebbastoni A, Pichiorri F, D'Antonio F, Campanelli A, Onesti E, Ceccanti M, de Lena C, Inghilleri M. Altered Cortical Synaptic Plasticity in Response to 5-Hz Repetitive Transcranial Magnetic Stimulation as a New Electrophysiological Finding in Amnestic Mild Cognitive Impairment Converting to Alzheimer's Disease: Results from a 4-year Prospective Cohort Study. Front Aging Neurosci. 2016 Jan 12;7:253. doi: 10.3389/fnagi.2015.00253. eCollection 2015.

    PubMed 26793103
  • Julkunen P, Jauhiainen AM, Westeren-Punnonen S, Pirinen E, Soininen H, Kononen M, Paakkonen A, Maatta S, Karhu J. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study. J Neurosci Methods. 2008 Jul 30;172(2):270-6. doi: 10.1016/j.jneumeth.2008.04.021. Epub 2008 Apr 29.

    PubMed 18533272
  • Elder GJ, Taylor JP. Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias? Alzheimers Res Ther. 2014 Nov 10;6(9):74. doi: 10.1186/s13195-014-0074-1. eCollection 2014.

    PubMed 25478032
  • Drumond Marra HL, Myczkowski ML, Maia Memoria C, Arnaut D, Leite Ribeiro P, Sardinha Mansur CG, Lancelote Alberto R, Boura Bellini B, Alves Fernandes da Silva A, Tortella G, Ciampi de Andrade D, Teixeira MJ, Forlenza OV, Marcolin MA. Transcranial Magnetic Stimulation to Address Mild Cognitive Impairment in the Elderly: A Randomized Controlled Study. Behav Neurol. 2015;2015:287843. doi: 10.1155/2015/287843. Epub 2015 Jun 16.

    PubMed 26160997
  • Wang JX, Rogers LM, Gross EZ, Ryals AJ, Dokucu ME, Brandstatt KL, Hermiller MS, Voss JL. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science. 2014 Aug 29;345(6200):1054-7. doi: 10.1126/science.1252900.

    PubMed 25170153
  • Rushworth MF, Behrens TE, Johansen-Berg H. Connection patterns distinguish 3 regions of human parietal cortex. Cereb Cortex. 2006 Oct;16(10):1418-30. doi: 10.1093/cercor/bhj079. Epub 2005 Nov 23.

    PubMed 16306320
  • Uddin LQ, Supekar K, Amin H, Rykhlevskaia E, Nguyen DA, Greicius MD, Menon V. Dissociable connectivity within human angular gyrus and intraparietal sulcus: evidence from functional and structural connectivity. Cereb Cortex. 2010 Nov;20(11):2636-46. doi: 10.1093/cercor/bhq011. Epub 2010 Feb 12.

    PubMed 20154013
  • Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6. doi: 10.1016/j.neuron.2004.12.033.

    PubMed 15664172
  • Wischnewski M, Schutter DJ. Efficacy and Time Course of Theta Burst Stimulation in Healthy Humans. Brain Stimul. 2015 Jul-Aug;8(4):685-92. doi: 10.1016/j.brs.2015.03.004. Epub 2015 Mar 26.

    PubMed 26014214
  • Suppa A, Huang YZ, Funke K, Ridding MC, Cheeran B, Di Lazzaro V, Ziemann U, Rothwell JC. Ten Years of Theta Burst Stimulation in Humans: Established Knowledge, Unknowns and Prospects. Brain Stimul. 2016 May-Jun;9(3):323-335. doi: 10.1016/j.brs.2016.01.006. Epub 2016 Jan 27.

    PubMed 26947241
  • Davis SW, Dennis NA, Buchler NG, White LE, Madden DJ, Cabeza R. Assessing the effects of age on long white matter tracts using diffusion tensor tractography. Neuroimage. 2009 Jun;46(2):530-41. doi: 10.1016/j.neuroimage.2009.01.068.

    PubMed 19385018
  • Davis SW, Kragel JE, Madden DJ, Cabeza R. The architecture of cross-hemispheric communication in the aging brain: linking behavior to functional and structural connectivity. Cereb Cortex. 2012 Jan;22(1):232-42. doi: 10.1093/cercor/bhr123. Epub 2011 Jun 7.

    PubMed 21653286
  • Kier EL, Staib LH, Davis LM, Bronen RA. MR imaging of the temporal stem: anatomic dissection tractography of the uncinate fasciculus, inferior occipitofrontal fasciculus, and Meyer's loop of the optic radiation. AJNR Am J Neuroradiol. 2004 May;25(5):677-91.

    PubMed 15140705
  • Kier EL, Staib LH, Davis LM, Bronen RA. Anatomic dissection tractography: a new method for precise MR localization of white matter tracts. AJNR Am J Neuroradiol. 2004 May;25(5):670-6.

    PubMed 15140704
  • Oberman L, Edwards D, Eldaief M, Pascual-Leone A. Safety of theta burst transcranial magnetic stimulation: a systematic review of the literature. J Clin Neurophysiol. 2011 Feb;28(1):67-74. doi: 10.1097/WNP.0b013e318205135f.

    PubMed 21221011

Questions about this trial

What is this clinical trial studying?

A study testing Transcranial magnetic stimulation (TMS) in people with Aging, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 6 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Episodic memory retrieval task decision (time frame: 40 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03406195, which also lists 19 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in